Skip to main content
. 2024 Apr 25;8(6):ziae058. doi: 10.1093/jbmrpl/ziae058

Table 3.

Associations between baseline heel eBMDa and incident CVDsa.

Outcome Model 1
n = 485 257
Model 2
N = 399 297
Model 3
n = 399 297
SHR (95% CI)
Ischemic heart disease 1.01 (0.99,1.02) 1.00 (0.98,1.01) 0.99 (0.98,1.01)
Myocardial infarction 1.00 (0.98,1.03) 1.00 (0.98,1.02) 1.00 (0.98,1.02)
Non-ischemic cardiomyopathies 0.96 (0.92,1.00) 0.95 (0.91,0.99) 0.95 (0.91,0.99)b
Heart failure 0.93 (0.91,0.95) 0.92 (0.90,0.94) 0.90 (0.89,0.92)b
Atrial fibrillation 0.98 (0.97,0.99) 0.97 (0.95,0.98) 0.95 (0.94,0.97)b
a

CVD, cardiovascular disease; eBMD, estimated bone mineral density.

b

Denotes a statistically significant result.

Results are reported as sub-distribution hazard ratios (SHR) per 1-SD increment of eBMD obtained from Fine and Gray competing risks model. Model 1 is adjusted for age and sex. Model 2 is adjusted for age, sex, diabetes, hypertension, high cholesterol, smoking status, alcohol intake frequency, physical activity, Townsend score, and educational level. Model 3: Model 2 + BMI.